Brian Mann
-
Ukrainian officials have vowed to retake the strategic city of Kherson. But the battlefield "gray zone," spanning more than 100 miles, is confusing — and danger can come in many forms. -
A 29-year-old battalion commander is leading 600 men, fighting in Ukraine's counteroffensive near Kherson. "This is war," Col. Serhiy Shatalov says. "You cannot predict nothing, absolutely nothing."
-
More than 20 people were killed when Russian missiles hit several buildings in Vinnytsia, a central city that has become a major logistical hub for humanitarian aid and military operations.
-
The Biden administration says it has a plan to curb fatal overdoses by 13% by 2025. But as more synthetic opioids reach the U.S., there's skepticism interdiction can slow the flow of deadly drugs.
-
A third of Ukrainians have called Russian their mother tongue. Russian statues and cultural markers abound. Are these influences inherently toxic? The war is prompting emotional conversations.
-
The Sacklers, who own Purdue Pharma, maker of Oxycontin, have maintained they did nothing wrong. People who lost loved ones and years of their lives to opioid addiction believe otherwise.
-
The deal, hashed out over weeks of intense negotiations, raises the amount paid by the Sacklers by more than $1 billion. In exchange, the family members win immunity from civil opioid lawsuits.
-
New research shows drug overdose deaths continue to surge among Black Americans. For the first time since 1999, Black Americans are dying at a higher rate per capita than white Americans.
-
The companies, including Johnson & Johnson and McKesson, will admit no wrongdoing. Billions of dollars in payouts will fund drug treatment and harm reduction programs.
-
Companies at the center of the deadly prescription opioid epidemic are close to deals that would cap their liability while funding drug treatment and recovery programs.
